Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
GreenLight Biosciences Holdings’ Go-Private Transaction
Goodwin Procter advised GreenLight Biosciences, Foley Hoag advised the Special Committee, while O’Melveny & Myers advised Fall Line on the deal. GreenLight Biosciences Holdings, PBC (NASDAQ:...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
iLearningEngines’ Merger with Arrowroot Acquisition Corp.
Goodwin advised Arrowroot Acquisition Corp. on the deal. Arrowroot Acquisition Corp. (NASDAQ:ARRW) announced its merger agreement with iLearningEngines. Upon closing of the transaction, the combined company will...
Berkshire Grey’s Merger Agreement with SoftBank Group
Goodwin advised Berkshire Grey, Inc. on the deal. Berkshire Grey, Inc. (Nasdaq: BGRY) announced its definitive merger agreement to be acquired by SoftBank Group Corp. and its...
Shanghai Jinmao Investment Management Group’s Issuance of Carbon Neutrality
Zhong Lun assisted Shanghai Jinmao Investment Management Group on the deal. Jinmao Investment Management Group Co., Ltd. successfully establishment of CITIC Securities – Jinmao Kaichen 2022...
Future Plc’s Acquisition of WhoWhatWear
Holland & Knight advised Future plc on the deal while Goodwin Procter represented Clique Brands. Future plc (LSE: FUTR), the global platform for specialist media, announced its...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...